Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 164 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/17/20
End: 09/17/24
Due: 09/17/25
Phase: N/A
Priority: Normal
Start: 11/12/14
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 12/22/17
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 11/30/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/23/16
End: 03/12/21
Due: 03/12/22
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 04/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/95
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 09/30/25
End: 09/30/30
Due: 09/30/31
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 05/24/18
End: 06/04/22
Due: 06/04/23
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 01/01/00
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 12/12/24
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 02/24/21
End: 07/27/22
Due: 07/27/23
Phase: N/A
Priority: Normal
Start: 01/21/22
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 11/11/21
End: 11/01/25
Due: 11/01/26
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 10/06/17
Due: 10/06/18